title: [Metabolic therapy at patients with a syndrome of diabetic foot].
authors.forename: V A
authors.initials: VA
authors.lastname: Stupin
authors.forename: S V
authors.initials: SV
authors.lastname: Goriunov
authors.forename: A I
authors.initials: AI
authors.lastname: Prividentsev
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000627:therapeutic use*; D017719:Diabetic Foot / Q000503:physiopathology / Q000628:therapy*; D004359:Drug Therapy, Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005500:Follow-Up Studies; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D019651:Plastic Surgery Procedures / Q000379:methods*; D012039:Regional Blood Flow; D012189:Retrospective Studies; D013524:Surgical Flaps; D013577:Syndrome; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D005343:Fibrinolytic Agents; D006025:Glycosaminoglycans; D007004:Hypoglycemic Agents; D007328:Insulin; D014665:Vasodilator Agents; C007858:glucuronyl glucosamine glycan sulfate; D000527:Alprostadil